Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2021

May 19, 2021

33298_dirs_2021-05-19_efcc5676-34b5-440c-90e0-6d3ef9051f34.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-05-19

Reporting Person: Benathen Marc David (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-19 Common Stock P 1099 $8.9334 Acquired 16339 Direct
2021-05-19 Common Stock P 317 $8.8073 Acquired 16656 Direct

Footnotes

F1: Jointly held with spouse

F2: The shares beneficially owned have been adjusted to reflect an additional 240 shares not previously reported.